Post-market Review of Pulmonary Arterial Hypertension (PAH) Medicines – Public Consultation

The public submission process is now open for the Post-market Review of Pulmonary Arterial Hypertension (PAH) Medicines.

Interested organisations and individuals are invited to provide a submission addressing the Review’s Terms of Reference.  To make a submission please go to the PAH Public Consultation page.

The public submission process will be open for 6 weeks and will close at 5pm AEDT Monday, 27 March 2017.

Further information on the Review is available on the PAH Review page.